Charles A. Dana Chair in Human Cancer Genetics;
Director, Center for Cancer Genomics
Dana-Farber Cancer Institute;
Professor of Genetics and Medicine
Harvard Medical School
Boston, Massachusetts
For significant discoveries including the identification of key oncogenic mutations and the development of genomic diagnostic approaches that have driven major advancements in cancer diagnostics and treatment. Dr. Meyerson’s groundbreaking work on CDK and telomerase genes, and EGFR and RAF mutations, has shaped targeted therapies and his discoveries in cancer microbiomics and non-coding genome alterations have deepened our understanding of tumor biology. His leadership in large-scale cancer genomics initiatives and mentorship of the next generation of cancer researchers have had a lasting impact on the field, advancing precision oncology and molecular pathology.
The AACR established the AACR James S. Ewing-Thelma B. Dunn Award for Outstanding Achievement in Pathology in Cancer Research in 2021 to recognize and celebrate pathologists who have significantly contributed to advancing cancer research, diagnosis, treatment, and prevention. To learn more please visit the press release.
View Dr. Meyerson’s Fellows of the AACR Academy page.
View Past Recipients.